Designing, DFT, biological, & molecular docking analysis of new Iron (III) & copper (II) complexes incorporating 1-{[-(2-Hydroxyphenyl) methylene] amino}− 5, 5 …

MM Khalaf, HM Abd El-Lateef, M Gouda… - … Biology and Chemistry, 2024 - Elsevier
The exploration encompassed the synthesis and characterization of two innovative
complexes, namely FePHNS and CuPHNS, employing a diverse array of analytical …

Designing, Characterization, DFT, Biological Effectiveness, and Molecular Docking Analysis of Novel Fe(III), Co(II), and Cu(II) Complexes Based on 4-Hydroxy-2H-pyrano[3,2-c] …

MM Khalaf, HM Abd El-Lateef, M Gouda… - ACS …, 2024 - ACS Publications
The main target of the current framework is the designing and synthesizing of novel iron (III),
cobalt (II), and cupper (II) complex compounds emanating from bioactive nucleus, 4-hydroxy …

Synthesis, structural, biological applications, DFT, molecular docking studies on Fe (III), Co (II), and Ni (II) complexes incorporating 2‐(pyridin‐2‐yl) phenol and 1H …

MM Khalaf, HM Abd El‐Lateef, A Abdou - Applied Organometallic … - Wiley Online Library
This study provides a detailed investigation into the synthesis, characterization, and
biological activities of the coordination compounds FePPHBZC, CoPPHBZC, and …

New Fe (III), Co (II), Ni (II), Cu (II), and Zn (II) mixed-ligand complexes: stractural, DFT, biological, and molecular docking studies

HM Abd El-Lateef, AM Ali, MM Khalaf… - Bulletin of the Chemical …, 2024 - ajol.info
The primary objective of the current framework was to synthesize novel mononuclear 1: 1: 1
complexes involving FeLG, CoLG, NiLG, CuLG, and ZnLG, where the ligand (L) is identified …

Designing, characterization, biological, DFT, and molecular docking analysis for new FeAZD, NiAZD, and CuAZD complexes incorporating 1-(2-hydroxyphenylazo)− 2 …

HM Abd El-Lateef, MM Khalaf, M Kandeel… - … Biology and Chemistry, 2023 - Elsevier
Herien, three new Fe (III)(FeAZD), Ni (II)(NiAZD), and Cu (II)(CuAZD) complexes were
synthesized and characterized using various physicochemical and spectroscopic …

Antibacterial, antifungal, anti‐inflammatory evaluation, molecular docking, and density functional theory exploration of 2‐(1H‐benzimidazol‐2‐yl)guanidine mixed …

HM Abd El‐Lateef, MM Khalaf, AA Amer… - Applied …, 2024 - Wiley Online Library
The aim of the present framework is to synthesize and characterize new cobalt (II)(C1),
nickel (II)(C2), and copper (II)(C3) mixed‐ligand complexes incorporating bioactive 8 …

Density functional theory/B3LYP study of nanometric 4‐(2,4‐dihydroxy‐5‐formylphen‐1‐ylazo)‐N‐(4‐methylpyrimidin‐2‐yl)benzenesulfonamide complexes …

FA Saad, MG Elghalban, NM El‐Metwaly… - Applied …, 2017 - Wiley Online Library
New metal ion complexes were isolated after coupling with 4‐(2, 4‐dihydroxy‐5‐formylphen‐
1‐ylazo)‐N‐(4‐methylpyrimidin‐2‐yl) benzenesulfonamide (H2L) drug ligand. The structural …

In silico, in vitro and docking exploration for some novel coordination complexes derived from bioactive indole moiety

NG Yernale, BS Mathada, G Baburao, S Sahane… - Journal of Molecular …, 2023 - Elsevier
Abstract The reaction of 5-methyl-3-phenyl-1H-indole-2-carbohydrazide with 4-
methoxybenzaldehyde gave the new ligand molecule; N'-(4-methoxybenzylidene)-5-methyl …

New Benzimidazole‐Based Fe (III) and Cr (III) Complexes: Characterization, Bioactivity Screening, and Theoretical Implementations Using DFT and Molecular …

NAA Elkanzi, AM Ali, M Albqmi… - Applied Organometallic …, 2022 - Wiley Online Library
Two new Fe (III) and Cr (III) complexes had been synthesized and structurally characterized.
The new complexes were based on 2‐methyl‐benzimidazole (MB) and salicylic acid (H2L) …

Synthesis, characterization, DFT, biological and molecular docking of mixed ligand complexes of Ni (II), Co (II), and Cu (II) based on ciprofloxacin and 2-(1H …

HM Abd El-Lateef, MM Khalaf, M Kandeel… - Inorganic Chemistry …, 2023 - Elsevier
In the present work, three new Cobalt (II)(CPFX1), Nickel (II)(CPFX2), and Copper
(II)(CPFX3) complexes based on Ciprofloxacin (CPFX), and 2-(1H-benzimidazol-2-yl) …